Trial intelligence / Profile preview

Lithium for Cannabis Withdrawal

NCT00114439Phase 2Completed

Sponsor
Sydney South West Area Health Service
Start
Sep 2005
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of lithium carbonate in cannabis withdrawal, sponsored by Sydney South West Area Health Service. Primary endpoints: Severity of reported cannabis withdrawal symptoms, Treatment retention and 5 more. Started Sep 2005; status: completed.

02

Drugs

lithium carbonate
03

Conditions

cannabis withdrawal

Beyond the preview

Go deeper on NCT00114439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00114439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call